204 related articles for article (PubMed ID: 36613908)
1. Comparative Analysis of Tumor-Associated microRNAs and Tetraspanines from Exosomes of Plasma and Ascitic Fluids of Ovarian Cancer Patients.
Yunusova N; Dzhugashvili E; Yalovaya A; Kolomiets L; Shefer A; Grigor'eva A; Tupikin A; Kondakova I; Tamkovich S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613908
[TBL] [Abstract][Full Text] [Related]
2. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding.
Yue S; Mu W; Erb U; Zöller M
Oncotarget; 2015 Feb; 6(4):2366-84. PubMed ID: 25544774
[TBL] [Abstract][Full Text] [Related]
3. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
[TBL] [Abstract][Full Text] [Related]
4. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression.
Zhao K; Wang Z; Hackert T; Pitzer C; Zöller M
J Exp Clin Cancer Res; 2018 Dec; 37(1):312. PubMed ID: 30541597
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis.
He L; Zhu W; Chen Q; Yuan Y; Wang Y; Wang J; Wu X
Theranostics; 2019; 9(26):8206-8220. PubMed ID: 31754391
[No Abstract] [Full Text] [Related]
6. Exosomal circNFIX promotes angiogenesis in ovarian cancer via miR-518a-3p/TRIM44 axis.
Ye H; Wang RY; Yu XZ; Wu YK; Yang BW; Ao MY; Xi MR; Hou MM
Kaohsiung J Med Sci; 2023 Jan; 39(1):26-39. PubMed ID: 36448712
[TBL] [Abstract][Full Text] [Related]
7. Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers.
Malla RR; Pandrangi S; Kumari S; Gavara MM; Badana AK
Asia Pac J Clin Oncol; 2018 Dec; 14(6):383-391. PubMed ID: 29575602
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
[TBL] [Abstract][Full Text] [Related]
9. Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients.
Tamkovich SN; Yunusova NV; Tugutova E; Somov AK; Proskura KV; Kolomiets LA; Stakheeva MN; Grigor’eva AE; Laktionov PP; Kondakova IV
Asian Pac J Cancer Prev; 2019 Jan; 20(1):255-262. PubMed ID: 30678441
[TBL] [Abstract][Full Text] [Related]
10. Exosomal Cargo in Ovarian Cancer Dissemination.
Dzhugashvili E; Tamkovich S
Curr Issues Mol Biol; 2023 Dec; 45(12):9851-9867. PubMed ID: 38132461
[TBL] [Abstract][Full Text] [Related]
11. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
[TBL] [Abstract][Full Text] [Related]
12. Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: Impact on tumor cell motility.
Rana S; Claas C; Kretz CC; Nazarenko I; Zoeller M
Int J Biochem Cell Biol; 2011 Jan; 43(1):106-19. PubMed ID: 20937409
[TBL] [Abstract][Full Text] [Related]
13. Exosome-derived miRNAs and ovarian carcinoma progression.
Vaksman O; Tropé C; Davidson B; Reich R
Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
[TBL] [Abstract][Full Text] [Related]
14. Distorted leukocyte migration, angiogenesis, wound repair and metastasis in Tspan8 and Tspan8/CD151 double knockout mice indicate complementary activities of Tspan8 and CD51.
Zhao K; Erb U; Hackert T; Zöller M; Yue S
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):379-391. PubMed ID: 29138006
[TBL] [Abstract][Full Text] [Related]
15. Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer.
Kobayashi M; Sawada K; Miyamoto M; Shimizu A; Yamamoto M; Kinose Y; Nakamura K; Kawano M; Kodama M; Hashimoto K; Kimura T
Biochem Biophys Res Commun; 2020 Jun; 527(1):153-161. PubMed ID: 32446360
[TBL] [Abstract][Full Text] [Related]
16. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
[TBL] [Abstract][Full Text] [Related]
17. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT.
Hang W; Feng Y; Sang Z; Yang Y; Zhu Y; Huang Q; Xi X
Int J Mol Med; 2019 Jan; 43(1):256-266. PubMed ID: 30365097
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions.
Cappellesso R; Tinazzi A; Giurici T; Simonato F; Guzzardo V; Ventura L; Crescenzi M; Chiarelli S; Fassina A
Cancer Cytopathol; 2014 Sep; 122(9):685-93. PubMed ID: 24888238
[TBL] [Abstract][Full Text] [Related]
20. Tspan8 and CD151 promote metastasis by distinct mechanisms.
Yue S; Mu W; Zöller M
Eur J Cancer; 2013 Sep; 49(13):2934-48. PubMed ID: 23683890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
